CP and Parkinson disease: Significant loss of ceruloplasmin-ferroxidase activity has been observed in CSF and substantia nigra of patients with Parkinson's disease (PD), suggesting a role of ceruloplasmin dysfunction in neurodegenerative diseases characterized by oxidative stress [3–7].